GANX icon

Gain Therapeutics

19 hedge funds and large institutions have $5.71M invested in Gain Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
19
Holders Change
+5
Holders Change %
+35.71%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
GC
1
Greenlight Capital
New York
$2.97M 546,560
TI
2
Telemetry Investments
New York
$807K 151,132 +54,900 +57%
CM
3
CM Management
Florida
$489K 90,000 +25,673 +40%
PCM
4
Prelude Capital Management
New York
$315K 58,100
BCM
5
Bridgeway Capital Management
Texas
$267K 50,000
V
6
Veritable
Delaware
$136K 25,064
Geode Capital Management
7
Geode Capital Management
Massachusetts
$107K 20,056 +20,056 New
Two Sigma Investments
8
Two Sigma Investments
New York
$106K 19,467 +19,467 New
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$103K 19,357 +19,357 New
Millennium Management
10
Millennium Management
New York
$84K 15,754 +15,754 New
Citadel Advisors
11
Citadel Advisors
Florida
$70K 13,029 +13,029 New
BlackRock
12
BlackRock
New York
$60K 11,159 -317 -3%
UBS Group
13
UBS Group
Switzerland
$57K 10,497 +3,757 +56%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$57K 10,560 +10,560 New
Osaic Holdings
15
Osaic Holdings
Arizona
$54K 10,050 +10,050 New
BCV
16
Banque Cantonale Vaudoise
Switzerland
$16K 3,000
TRCT
17
Tower Research Capital (TRC)
New York
$7K 1,170 +615 +111%
Morgan Stanley
18
Morgan Stanley
New York
$4K 800
IAP
19
Indie Asset Partners
Indiana
-29,652 Closed
SPIA
20
Steward Partners Investment Advisory
New York
-100 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
Wells Fargo
22
Wells Fargo
California
$0 23